Anavex Life Sciences Corp (AVXL)

[Gator328]

Share price is a reflection of the perceived value of a company’s future cash flow. Right now it’s very hard to determine the future cash flow because the drug isn’t even approved yet and if/when it does get approval, there are no assurances that it will become the standard of care. We all hope and expect it will but who knows?

I believe that Dr. Missling is the right CEO for the task of getting A273 approved. I don’t know if he’s the best fit for marketing the drug to physicians, caregivers and patients. But that’s way down the line, and not worth discussing until there is actually a drug available to market.